Mild Cognitive Impairment (MCI) marks a critical stage preceding Alzheimer's Disease and other types of dementia. It involves subtle changes in cognitive functions like memory and reasoning that exceed normal age-related decline. While individuals with MCI may struggle with remembering recent events or making decisions, these challenges typically do not significantly disrupt daily life.
Understanding MCI's significance lies in its potential progression to dementia, although this progression isn't inevitable. Some individuals with MCI remain stable or may even show improvement over time. Early detection and intervention are vital, as lifestyle adjustments, cognitive training, and certain medications could potentially slow down or manage further cognitive decline.
Ongoing research aims to deepen our understanding of MCI's origins, risk factors, and effective interventions, with the goal of improving outcomes and enhancing the quality of life for individuals at risk of developing dementia.
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Association between APOE allele prevalence and Alzheimer's disease risk in Southwestern Uganda
Frank Balikoowa, African Research Center for Ageing & Dementia, Uganda
Title : Healthcare professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia
Title : Association between depressive symptoms and cognitive impairment severity in a real-world memory clinic cohort
Yun Ju Hsieh, Taipei City Hospital, Taiwan
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China